Adage Capital Partners
CINC

Adage Capital Partners’s CinCor Pharma, Inc. Common Stock CINC Stock Holding History

Adage Capital Partners’s Portfolio CINC Stock Details CINC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-1,994,583
Closed -$24.5M – 1066
2022
Q4 		$24.5M Sell
1,994,583
-1,034,844
-34% -$24.7M 0.06% 370
2022
Q3 		$99.4M Buy
3,029,427
+763,966
+34% +$21.6M 0.25% 93
2022
Q2 		$42.7M Buy
2,265,461
+176,448
+8% +$3.38M 0.1% 217
2022
Q1 		$36.6M Buy
+2,089,013
New +$42.9M 0.07% 297

Adage Capital Partners's CINC Position: Q1 2023 in Review

Adage Capital Partners sold out of CinCor Pharma, Inc. Common Stock (CINC) in Q1 2023, closing a stake of 1,994,583 shares — an estimated $24.5M sold.

Adage Capital Partners first reported a position in CINC in Q1 2022 and held it in 4 quarters. The position peaked at $99.4M in Q3 2022. 0 funds tracked by Wall St. Rank hold CINC as of Q1 2023.

  • Adage Capital Partners reported no remaining CinCor Pharma, Inc. Common Stock position as of Q1 2023 after selling out during the quarter.
  • Adage Capital Partners sold 1,994,583 CinCor Pharma, Inc. Common Stock shares in Q1 2023, an estimated $24.5M.
  • Adage Capital Partners first reported a position in CinCor Pharma, Inc. Common Stock in Q1 2022 and held it in 4 quarters.
  • Adage Capital Partners's CinCor Pharma, Inc. Common Stock position peaked at $99.4M in Q3 2022.
  • 0 funds tracked by Wall St. Rank held CinCor Pharma, Inc. Common Stock as of Q1 2023.

Based on Adage Capital Partners's 13F filing for Q1 2023, filed 15 May 2023.